Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

In the News

News Review
VIDEO: Herceptin and Chemotherapy Treatment Combo Increases Survival Rates in Early Breast Cancer Patients
Posted Date: 11/10/2011 11:00 AM

Dr. Dennis SlamonIn this NBC Nightly News video, watch UCLA Jonsson Comprehensive Cancer Center researcher Dr. Dennis Slamon discuss the results of a new study that finds that treating women with a combination of chemotherapy and the molecularly targeted drug Herceptin can significantly increase survival in patients with a specific genetic mutation that results in very aggressive disease.

Watch the video.

 

 

Save/Share
Mixx Google Digg Reddit Facebook Yahoo! Newsvine MySpace